Melatonin is a small molecule drug that acts on melatonin receptors, functioning as an agonist. It is primarily used to treat sleep initiation and maintenance disorders, including insomnia, and has also been investigated as a potential treatment for autism spectrum disorder and delirium. In addition, it has been studied as a potential therapy for COVID-19, with some evidence suggesting that it may have a beneficial effect in reducing symptoms and severity of the disease. Melatonin was first approved as a drug in 2005, and its safety and efficacy have been well-established in numerous clinical studies over the years. Click on the image below to begin the exploration journey of Melatonin through the Synapse database!
You can search for the latest pharmaceutical information such as drugs, targets, patents, transactions, clinical results, etc. through the Synapse database. Come and experience it!